chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient started experiencing dizziness; Noticed her arm was swollen at the injection site; Noticed her arm was red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Patient started experiencing dizziness), VACCINATION SITE SWELLING (Noticed her arm was swollen at the injection site) and VACCINATION SITE ERYTHEMA (Noticed her arm was red at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. LCHD) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.    On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Noticed her arm was swollen at the injection site) and VACCINATION SITE ERYTHEMA (Noticed her arm was red at the injection site). On 28-Jan-2021, the patient experienced DIZZINESS (Patient started experiencing dizziness). The patient was treated with PARACETAMOL (TYLENOL) on 27-Jan-2021 for Adverse event, at a dose of two tylenol. At the time of the report, DIZZINESS (Patient started experiencing dizziness), VACCINATION SITE SWELLING (Noticed her arm was swollen at the injection site) and VACCINATION SITE ERYTHEMA (Noticed her arm was red at the injection site) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event, included blood pressure medication.
EYELID DROOPINESS, LOSS OF MOTION IN FOREHEAD,EYEBROWS. PAIN OVER RIGHT EYE. TIGHTNESS ACROSS FOREHEAD.
5 hrs p/vax pt devel difficulty breathing; mom noticed that pt appeared to be grasping for air while slept; also states that pt appeared to have stopped breathing;
This is a spontaneous report received from a contactable nurse (patient). A female patient, of an unspecified age, received the 3rd (booster) dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Patient previously received the first and second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date; single dose, for COVID-19 immunisation. Reportedly, 2 weeks ago a guy said he was having  a side effect from the COVID-19 vaccine. The caller highly doubts it was true because she thinks the guy was an anti-vaxxer. He was spreading disinformation. There was nothing on Pfizer's website that says about where to report people who are disinforming the public. During the original report, she mentioned she had her 3rd shot of the Pfizer COVID-19 vaccine on an unspecified date and experienced sore arm and tiredness on an unspecified date. The outcome of events: unknown. The lot number for the vaccine, BNT162B2, not provided and will be requested during follow-up.
The first dose on Aug 3 left me with extreme nausea, moderate joint soreness and muscle weakness. I was extremely fatigued that afternoon. I started having chest congestion and sought medical treatment at a Pulmonologist clinic. I was given two injections. One was an antibiotic, I think it was Doxycycline but I?m not sure. I believe the other to be an antibiotic. I was also given a prescription for Doxycycline, 10mg Prednisone and Fluconazole 150mg. I was sent for a low dose cat scan and have yet to receive the results from that. I received the second Moderns vaccination on Aug 31, 2021. Again, the nausea started a few hours after receiving the shot. This time it?s much worse! I haven?t vomited, but my stomach is literally churning. The location of the shot unreasonably swelled up . I?ve been icing that. I don?t have any fever, but I feel terrible. I?m completely exhausted  and my have aches and pains throughout my body. It?s flu like without the vomiting.
Donor has 2.25 inch x 1 inch localized tenderness, redness, swelling, and warm to touch in left deltoid on 09/07/2023.
headache, sore throat, cough, fatigue, body aches, chills. starting 12/17/21
Patient had large red spot at injection site, had flu-like symptoms that lasted 5 days after the injection. Patient had similar reaction with the first dose as well
On Tues Eve 3/16, still had bruising & heat at injection site . Wed am 3/17 itching, redness & soreness, by evening had a cellulitis like welt, hard & waffle feel itching. On Thurs 3/18 the welt  got larger & itching became quite severe.  Fri 3/19 the same. Sat 3/20 still hard, red & hot, welt same size. Itching subsided a bit.  Sun 3/21, welt down,  less hot but still warm, itching less, site reddish
Pt recvd 3 doses of Engerix-B 09NOV90, 13DEC90, & 15MAY91 & it was determined that pt did not seroconvert;
Pt. immediately begin to have urticaria that began on chest then on both (L) and (R) aspects of neck. There were a total of 11 hives. This was the only reaction the Pt. had. No resp. distress. It did not worsen. A steroid was given IM as well as diphenhydramine. The Pt. was monitored for approx. 1 hour. Pt. received  2 mg. dexamethasone IM and 12.5 mg. of diphenhydramine. He was monitored for about 1 hour. His urticaria did go away. Mom was educated to give diphenhydramine every 6 hours around the clock for the next 48 hours. She was advised to monitor the pt. and if he began to have any additional skin problems such as urticaria and/or rash and especially if he began to have difficulty breathing, she was advised to take him immediately to the ER.
Patient's mother came back to the pharmacy stating her daughter had just gotten her Covid shot and was not feeling well. Pharmacist went out to patient and asked what patient was feeling. Patient stated that she started to walk around and was feeling dizzy and lightheaded. Pharmacist asked if patient would like some water and mother went to car to get patient's water. During that time, patient stated that she started to fell better and dizziness/lightheadedness was subsiding. Patient took a few sips of water as well. Patient was asked to stay an additional 15 minutes and to walk around the store a bit to see if she was still feeling well. Patient's mother stated she would drive her as well.
Initial report received on from a healthcare professional on 18 May 2012. A male patient, whose age, medical history and concomitant medications were not reported, had received a dose of MENACTRA vaccine (batch number, route of administration were not reported) and HPV on the same arm and a dose of Tdap vaccine (batch number, route and site of administration were not reported) on 17 May 2012. The reporter stated that, after vaccination on 17 May 2012, the patient left office and was fine, no bleeding. Later in the middle of night, the patient woke up bleeding from the site where MENACTRA vaccine was given. There was significant blood which was all over the bathroom and all over the floor. When the patient was seen on 18 May 2012, the bleeding had stopped and there was no bruising however there was a red spot about 2.5 in X 1 in about 2 in below the injection site which does not look like it was scratched. The corrective treatments were not reported. The event of bleeding was stopped (date was not specified) and the outcome of event red spot was not reported. List of documents held by sender: None.
Status post robotic right knee replacement. Hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On 10-MAR-2016, the patient was vaccinated with VARIVAX (Merck) lot # K026386 expiry date 15-DEC-2016, 0.65 ml, subcutaneously instead of ZOSTAVAX (wrong vaccine administered). No adverse effects were reported. No concomitant medications were reported. There was no product quality complaint involved. Additional information has been requested.
patient had dizziness, headache and nausea. bp was 127/89 HR 87. Patient was evaluated by a doctor that was working vaccination clinic. instructed to take tylenol. No further intervention required.
Submitted to Docket No. 1980N-0208; 69 FR 78281, December 29, 2004 - Bacterial Vaccines & Toxoids Efficacy Review Proposal. Please reconsider your efforts to approve the anthrax vaccine. prior to receiving the anthrax vaccine, I was an extremely healthy and active individual. When I was notified in 1999, that as a member of the national guard, I would be required to take the series of injections, I thought it was a great idea. I trusted that the required testing had been accomplished and this could benefit me and other military members from a possible exposure to anthrax. The first odd thing I noticed was about a 20 pound weight gain even though I continued to be very active. I blamed that on my age (being over 40). In the summer of 2000, I took my fifth injection. Approximately one month later, I began to notice joint pain and stiffness as well as rashes for no reason. The following January (2001), during a routine physical, I explained my symptoms to my physician who ordered a series of labs and x-rays. The results led to appointments with a number of specialists which has been ongoing since. During the past 4.5 years, I have had thyroiditis, pain and stiffness in all joints, sudden unexplained abdominal pains, irregular heart rate (premature atrial contractions) that has been severe enough to send me to the emergency room twice, respiratory problems, vision problems, non-injury tendon tears (requiring surgery) and numbness in my hands and feet. The pain in my joints is so severe; it hinders my sleep and daily activities. I take daily medications to alleviate the pain; medications to improve circulation in my hands and feet, and medications to help me breathe better. I am no longer able to run, using the stairs is painful, and I am so stiff after short periods of inactivity that I make sure I have something to hold onto when I arise in the mornings to keep from falling. When I expressed my concerns to a doctor in 2001, he told me there was no way to prove these things would not have happened to me anyway. He is right and I cannot prove it. All I can say is, since taking the anthrax vaccines, my health has declined considerably and so has my active lifestyle.
A 45-year-old female patient had inadvertently received a left deltoid, intramuscular injection of Daptacel, (product not recommended for use in this age group), lot number C2630AA, on 01 September 2006. This product was administered instead of Adacel. The following day, the patient experienced muscle soreness. No testing or examination by a physician was required. The patient took non steroidal anti-inflammatory medications as needed. The patient recovered from the event with in 96 hours.
Pt given FLUVIRIN vaccine on 9/6/10 called 9/7/10 c/o vomiting on 9/6/10 and again on 9/7/10.
Vaccine was stored in the refrigerator on 02-Mar-2022, patient received Monovalent shots on 04-Apr-2022; No adverse event; Received Expired Monovalent vaccine after 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent vaccine after 30-day Use By Date), PRODUCT STORAGE ERROR (Vaccine was stored in the refrigerator on 02-Mar-2022, patient received Monovalent shots on 04-Apr-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 046L21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent vaccine after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in the refrigerator on 02-Mar-2022, patient received Monovalent shots on 04-Apr-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent vaccine after 30-day Use By Date), PRODUCT STORAGE ERROR (Vaccine was stored in the refrigerator on 02-Mar-2022, patient received Monovalent shots on 04-Apr-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent vaccine after 30-day Use By Date) and PRODUCT STORAGE ERROR (Vaccine was stored in the refrigerator on 02-Mar-2022, patient received Monovalent shots on 04-Apr-2022).    No concomitant medications were reported. The vial could be either from individual vials or unbroken cartons and was of the size of 2.5 ml. 1 Adult patient received Monovalent shots on 04-APR-2022 from vial shipped in 02-MAR-2022 thawed in a cooler while being transported. The vial did not undergo any temperature excursions. Treatment information was not provided. This case was for adult patient who received monovalent dose on 04-Apr-2022, as described by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Dec-2022: Live Significant follow up received: Reporter added and narrative updated.
Information has been received from a Nurse Practitioner referring to an 11 month old patient of unknown gender. There was no medical history or drug reaction/allergies reported. On 01-DEC-2010, the patient was vaccinated with the first dose of M-M-R II (dose, route and lot# were unknown) (inappropriate schedule of drug administration). The second dose of M-M-R II was administered on an unspecified date after the patient's 4th year birthday (inappropriate schedule of drug administration). No concomitant medication was provided. No adverse effect was reported. Additional information has been requested.
RASH, SORE THROAT, NOT FEELING WELL, SLIGHT FEVER; LASTED A FEW DAYS.
Given expired Janssen booster vaccine, expired 1/20/22 at 6:14 pm and stored in refrigerator overnight. Patient experiencing no adverse events at this time, will be re-vaccinated.
began itching; rash down my arm down to my elbow; sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash down my arm down to my elbow), PRURITUS (began itching) and VACCINATION SITE PAIN (sore at the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced RASH (rash down my arm down to my elbow), PRURITUS (began itching) and VACCINATION SITE PAIN (sore at the injection site). At the time of the report, RASH (rash down my arm down to my elbow), PRURITUS (began itching) and VACCINATION SITE PAIN (sore at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Incorrect amount of diluent introduced to the Pediatric Pfizer vial. Correct dose in mL given. Mistake caught before any other patients were affected. Father indicated on 7/25 that she was experiencing malaise, insomnia, and was afebrile. No treatment given at the time of the incident as it was discovered after they had left.
Lost of memory, fatigue, dizziness, lost of vision, gained weight, headaches, skin rash.
Left swollen eye with itching both eyes (mom states "rubbing eyes"). Child says "yes" to itching. No difficulty breathing; No difficulty swallowing denies pain 30-45 minutes after injection swelling. Returned to health unit 45-1 hour post injection. Ice bag to eye and referred to ER). Follow up on 08/31/04 states: "08/10/04: telephone call to mother of pt.  Did not go to ER for evaluation. Gave child antihistamine and the problem resolved; per RN."
urticaria, swelling L axilla, unusual odor to urine. symptoms persist 6/11/2021
Brain fog-August 12-current dizziness- August 10 to current Disassociation- August 12to current Severe anxiety-august 10 to current burning in chest and arms- August 17 to current (happens sporadically)
Approx. 11 hours after injection I developed a low grade fever accompanied by extreme headaches and full body aches. Pain impacts daily life activity.
Initial information received on 19-Oct-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves 12 adult patients (age and gender was not reported) who experienced hives, high BP, headache and shortness of breath, while he/she received vaccine FLUBLOK QIV. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 19-Oct-2018, the patient received a 0.5 ml dose of suspect Influenza Quadrivalent Recombinant Vaccine, lot QFAA1821 via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious hives (urticaria), high BP (hypertension), headache, shortness of breath (dyspnoea), following the administration of Influenza Quadrivalent Recombinant Vaccine. No lab data reported. Final diagnosis was shortness of breath, headache, high BP and hives. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for all the events.
Information has been received from a physician concerning a 9 week old male who on 27-APR-2007 was vaccinated with a 1 ml oral dose of Rotateq (Lot# unavailable). Concomitant vaccines included a dose of Ipol, a dose of Recombivax HB (manufacturer unknown), a dose of diptheria toxoid (+) pertussis acellular vaccine (unspecified (+) tetanus toxoid, a dose of Pedvaxhib (manufacturer unknown) and a dose of Prevenar. On 01-MAY-2007 the patient was hospitalized for severe diarrhea and pneumatosis intestinalis. It was reported that the patient was discharged from the hospital and was recovered. No product quality complaint was involved. No other information was provided. The patient's experiences were considered to be immediately life-threatening by the reporter. Additional information has been requested.
At approximately 11:00 AM on 05/06/2014, I noticed I felt tired and little sluggish; this increased as the day wore on. By late afternoon, I had a mild headache (None of the above symptoms would be worth reporting except...) By the time I got home at 9:30 PM on 05/06/2014, I was not feeling well and thought I might vomit. I immediately went to bed and despite chills was able to sleep for about an hour. At 10:30 PM on 05/06/2014, I was violently sick to my stomach. I also had chills and body pain. At 2:30 AM on 05/06/2014, I was again sick - this time with dry heaves as there was nothing left in my stomach. Chills and body pain continued. Throughout the day on 05/07/2014, I had water, crackers, and room temperature Coke. At 11:00 AM, I had intestinal distress and mild cramping. After sleeping the majority of the day, I felt better. As of 3:50 PM on 05/07/2014, the nausea passed but the body pain, stiffness and soreness remain. When my doctor's office called at 1:00 PM on 05/07/2014, I reported the reaction to the nurse practitioner that called.
Within a couple of days of receiving the vaccine I developed ovarian pain (similar to ovulation pain, but stronger).  This lasted for at least a week and was accompanied by copious clear discharge.  I initially thought I had developed a yeast infection, but the discharge was not the same. It felt like I was going through puberty again at the age of 57.  I visited my doctor's office, but couldn't see my own doctor. The doctor I saw just kind of shrugged it off.  I was hoping it would be reported to VAERS, but it was not. The symptom lasted 3-4 weeks and then gradually subsided.
Patient has a rash at rt side T5 & T11 area. T5 area started on 8/22/2009, T11 area started on 8/24/09. Shingles in Rt T5 & T11 distribution. VALTREX Rx given.
Patient reported to clinic stating he wanted to get his first dose of Janssen vaccine in order to obtain a $100 grocery gift certificate being offered as an incentive. He was given the vaccine with no issues during or after. Another staff member mentioned that this person reported having had gotten Janssen earlier in the day to her. The staff member did not notify me about this until after the patient had gotten a second dose. The patient denied getting a first dose on the screening form. By checking database I was able to determine that he did get a J&J vaccine on 4/28/21. Patient appears to have waited for the end of the day to get another vaccine so that he could get the incentive gift card.
underneath the injection arm it is puffy and appears fat and swollen; injection site itches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (underneath the injection arm it is puffy and appears fat and swollen) and VACCINATION SITE PRURITUS (injection site itches) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and High cholesterol.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE SWELLING (underneath the injection arm it is puffy and appears fat and swollen) and VACCINATION SITE PRURITUS (injection site itches). At the time of the report, VACCINATION SITE SWELLING (underneath the injection arm it is puffy and appears fat and swollen) and VACCINATION SITE PRURITUS (injection site itches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was taking unspecified medications for high blood pressure and high cholesterol. Treatment details were not reported.
I woke up with extreme lower back pain, pelvic and uterus pain. I have a high pain tolerance. This has never happened to me.  Lasted for maybe an hour or two.. I tried sleeping it off so I am unsure.